Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Host microbe dialogue through metabolic interactions

Objectif

The intestinal microbiome is a complex community of organisms that exists in symbiosis with its host. Microbiota perform essential digestive, metabolic, and immunomodulatory functions in health, and disturbance of the microbiota can contribute to disease. Microbial metabolites are a key ingredient in healthy host-microbe dialogue, bolstering barrier immunity and immune regulatory pathways. Our recent work on microbiota-derived small molecule metabolites ADP-heptose and the short chain fatty acid, butyrate, has identified new immune regulatory and microbicidal functions that could be targeted in inflammatory bowel disease. However, harnessing metabolites as disease therapeutics has been challenging because of their diverse cellular targets and the complex bacterial community ecology governing their production and function. Using our recent technological advances we propose a multi-disciplinary approach spanning the frontiers of immunology, cell biology, gnotobiology, microbial ecology and computational biology, to deconvolute host microbiota interactions over space and time. Using ADP-heptose and butyrate as exemplars, we will use metabolite-centric designer microbiome communities together with integrated spatial, omics-scale data in tissue sections, to chart the passage of microbiota-derived metabolites into tissue niches to reveal their cellular targets and influence on transcriptomic and proteomic networks relevant to immune regulatory and microbicidal function. In addition to our in vitro-defined cellular pathways, this will identify novel interkingdom targets and opportunities to treat disease niches, leaving other metabolic pathways and cellular interactions unaffected. Results of these studies will be used to design new vaccine enhancing strategies and more specific therapeutic approaches in IBD patients.

Champ scientifique (EuroSciVoc)

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2025-ADG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Contribution nette de l'UE
€ 2 499 598,00
Adresse
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Royaume-Uni
Région
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Bénéficiaires (1)